A major pharmacy chain has agreed to pay $315 million to resolve a Justice Department lawsuit alleging it contributed to the opioid crisis by improperly distributing prescription painkillers. The settlement follows allegations that the company failed to monitor suspicious orders and did not report potential diversions of controlled substances. Authorities claim the practices enabled widespread opioid misuse across the country. The case underscores ongoing legal and regulatory scrutiny of pharmaceutical and healthcare providers in addressing the nation’s opioid epidemic.
CVS settles US Justice Department case over opioid prescriptions for $315 million Reuters
